Search
01/03/2025
Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital
Rueda-Lara, A, Viñal, D, Martínez-Pérez, D, Alameda-Guijarro, M, Martin-Montalvo, G, Martínez-Recio, S, Peña-Lopez, J, Jiménez-Bou, D, Ruíz-Gutiérrez, I, García-Leal, A, Zwisler-Contreras, P, Ghanem, I, Custodio, AB, Pérez-Wert, P, Gutiérrez-Sainz, L, Palacios, ME, Feliu, J, Rodríguez-Salas, N. Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital. ONCOLOGIST. 2025; 30(3)DOI:10.1093/oncolo/oyaf027. PMID:40152315. IF:4.200(Q2/3D).
01/03/2025
CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model
Szafranska, J, Batto, V, Alcaraz, J, Guinart-Cuadra, A, Brujats, A, Fajardo, J, Acin, V, Garcia, H, Casani, L, Villanueva, C, Ferré, M, del Olmo, TV, Tapias, EA. CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103704. PMID:. IF:4.200(Q1/1D).
01/03/2025
Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens
Kelley, J, Hissong, E, Szafranska, J, Qin, LH, Lamps, L, Jessurun, J. Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102849. PMID:. IF:4.200(Q1/1D).
01/03/2025
Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas
D'Angelo, E, Kingsley, L, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103197. PMID:. IF:4.200(Q1/1D).